Tagged with Artificial Intelligence

Emily Morris – Head of Latin America, GM & Country Pharma Lead, Mexico, Sanofi
Revolutionising Drug Discovery: Five Companies at the Forefront of AI-Driven Medicine
Pharma’s AI Push Continues with Lilly’s First ‘Chief AI Officer’
Responsible Use of AI in Healthcare: A Work in Progress
Ronald Tam – CFO, XTALPI
Could Human HTA Committees be Replaced with AI Systems?
Can the EU AI Act Be Applied and Regulated in the Pharma Industry?
Mahmoud Alyamani – Health & Well-Being Sector Head, NEOM
Lars Bo Nielsen – Director General, Danish Medicines Agency (DKMA)
Adopting AI in Pharma: Start with the Problem, Not the Technology
Saskia Steinacker – Senior Vice President, Global Head Strategy and Digital Transformation (IT), Bayer
4 Key Insights for Pharma and Healthcare from Davos 2024
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here